Biorigin joins European beta-glucan bandwagon
The Brazilian company Biorigin has announced plans to develop its position in the European beta-glucan market after winning EU novel foods approval; meanwhile the EU health claim scramble continues.
Archives for September 16, 2013
Packaged Facts: Non-GMO foods will account for 30% of US food and beverage retail sales by 2017
US retail sales of non-GMO foods and beverages are projected to increase at a compound annual growth rate (CAGR) of 12.9% in the next five years, and could represent 30% of the market with a value of $264bn in 2017, predicts Packaged Facts.
‘Timely’ research: Higher omega-3 levels linked to lower risk of depressive symptoms
American women with higher blood levels of omega-3 fatty acids have a 49% reduction in risk of elevated depressive symptoms, a result that has been hailed as ‘timely’ by a leading industry expert.
Probiotics can benefit colitis sufferers with ‘anal pouch’ issues: Study
Ulcerative colitis (UC) sufferers who are surgically fitted with an artificial anus (‘ileoanal pouch’) can benefit from probiotics, Swedish and Dutch researchers have found.
Former MHRA expert appointed to ELC Group advisory board
ELC Group, the global services organisation which specialises in regulatory affairs has welcomed clinical scientist and former MHRA assessor John Warren to its advisory board this week.
Novel keratin ingredient may relieve joint pain and stiffness: RCT data
Daily intake of a keratin-based dietary supplement may provide relief for the symptoms of knee osteoarthritis, suggest results of a clinical trial published in the Journal of Dietary Supplements.
Valensa teams with Algaeon for algae-based nutraceuticals
Florida-based Valensa International has signed a multi-year, multi-million-dollar agreement with algae-based supplement maker Algaeon Inc. to bring “condition-specific” nutraceuticals to the marketplace.